CLPBY (Coloplast AS) Total Receivables : $750 Mil (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Coloplast AS Total Receivables?

Coloplast AS's Total Receivables for the quarter that ended in Sep. 2024 was $750 Mil.

Coloplast AS Total Receivables Historical Data

The historical data trend for Coloplast AS's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Total Receivables Chart

Coloplast AS Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Total Receivables

Get a 7-Day Free Trial

518.14

543.94

575.10

656.58

750.37

Coloplast AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Receivables	Get a 7-Day Free Trial															656.58	748.23	728.16	739.73	750.37

Coloplast AS Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Coloplast AS Total Receivables Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBY) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

CLPBF:USA COLOBc:UK 0QBO:UK COLO B:Denmark CBH:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.